Tierney Hannah R, Rowe Christopher L, Coffa Diana A, Sarnaik Shashi, Coffin Phillip O, Snyder Hannah R
School of Medicine, University of California, San Francisco, 500 Parnassus Avenue, San Francisco, CA 94143 (HRT, DAC, POC, HRS); San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 500, San Francisco, CA 94102 (CLR, POC); Department of Family and Community Medicine, University of California, San Francisco, 1001 Potrero Avenue, SFGH 80, San Francisco, CA 94110 (DAC, SS, HRS).
J Addict Med. 2022;16(2):169-176. doi: 10.1097/ADM.0000000000000851.
Describe clinical and demographic associations with inpatient medication for opioid use disorder (MOUD) initiation on general medicine services and to examine associations between inpatient MOUD initiation by generalists and subsequent patient healthcare utilization.
This is a retrospective study using medical record data from general medicine services at an urban safety-net hospital before an inpatient addiction consultation service. The patients were adults hospitalized for acute medical illness who had an opioid-related ICD-10 code associated with the visit. Associations with MOUD initiation were assessed using multivariable logistic regression. Hospital readmission, emergency department use, linkage to opioid treatment programs (OTP), and mortality at 30- and 90-days postdischarge were compared between those with and without hospital MOUD initiation using χ2 tests.
Of 1,284 hospitalized patients with an opioid-related code, 59.81% received MOUD and 31.38% of these were newly initiated in-hospital. In multivariable logistic regression, Black race, mood disorder, psychotic disorder, and alcohol use disorder were negatively associated with MOUD initiation, while being aged 25-34, having a moderate hospital severity of illness score, and experiencing homelessness were positively associated. There were no bivariate associations between MOUD initiation and postdischarge emergency department use, hospital readmission, or mortality at 30- and 90-days, but those initiated on MOUD were more likely to present to an OTP within 90 days (30.57% vs 12.80%, P < 0.001).
MOUD prescribing by inpatient generalists may help to increase the number of patients on treatment for opioid use disorder after hospital discharge. More research is needed to understand the impact of inpatient MOUD treatment without addiction specialty consultation.
描述在综合内科服务中与启动阿片类物质使用障碍住院药物治疗(MOUD)相关的临床和人口统计学关联,并研究通科医生启动住院MOUD与患者后续医疗保健利用之间的关联。
这是一项回顾性研究,使用了一家城市安全网医院在设立住院成瘾咨询服务之前综合内科服务的病历数据。患者为因急性内科疾病住院的成年人,其就诊与阿片类物质相关的ICD-10编码有关。使用多变量逻辑回归评估与启动MOUD的关联。使用χ2检验比较了启动和未启动住院MOUD的患者在出院后30天和90天的再入院情况、急诊科就诊情况、与阿片类物质治疗项目(OTP)的联系以及死亡率。
在1284名有阿片类物质相关编码的住院患者中,59.81%接受了MOUD,其中有医院新启动MOUD的占31.38%。在多变量逻辑回归中,黑人种族、情绪障碍、精神障碍和酒精使用障碍与启动MOUD呈负相关,而年龄在25 - 34岁、医院疾病严重程度评分为中度以及经历无家可归与启动MOUD呈正相关。启动MOUD与出院后急诊科就诊、再入院或30天和90天死亡率之间没有二元关联,但启动MOUD的患者在90天内更有可能前往OTP就诊(30.57%对12.80%,P<0.0??1)。
住院通科医生开具MOUD可能有助于增加出院后接受阿片类物质使用障碍治疗的患者数量。需要更多研究来了解在没有成瘾专科会诊的情况下住院MOUD治疗的影响。